27576084|t|Polymeric Nanostructure Compiled with Multifunctional Components To Exert Tumor - Targeted Delivery of Antiangiogenic Gene for Tumor Growth Suppression
27576084|a|Nucleic acid-based therapy has emerged as a revolutionary methodology for treatment of the diseases related to protein dysfunction; however, lack of systemically applicable synthetic delivery systems limits its current usage in local applications, particularly for DNA-based therapy with regard to the poor bioavailability in the systemic administrations. To overcome this obstacle, we compiled multiple chemistry-based strategies into the manufacture of the gene delivery formulations to pursue improved tolerability of DNA to the enzymatic degradation in the biological milieu and prolonged retention in the systemic circulation. Here, we constructed a distinctive multilayered functional architecture: plasmid DNA (pDNA) was electrostatically complexed with cationic poly(lysine) (polyplex) as the interior pDNA reservoir, which was further cross-linked by redox - responsive disulfide cross-linking to minimize the occurrence of polyplex disassembly through exchange reaction with the biological charged components. Still, the pDNA reservoir was spatially protected by a sequential thermoresponsive poly(N-isopropylacrylamide) palisade as the intermediate barrier and a biocompatible hydrophilic poly(ethylene glycol) (PEG) shell with the aim of preventing the accessibility of the biological species, particularly the nuclease degradation to the pDNA payload. Subsequent investigations validated the utilities of these strategies in accomplishing prolonged blood retention. In an attempt to apply this method for tumor therapy, ligand cyclic (Arg-Gly-Asp) peptide was attached at the distal end of PEG, validating prompted tumor - targeted delivery and gene expression of the loaded antiangiogenic gene at the targeted tumor cells and accordingly exerting antiangiogenesis of the tumors for abrogation of tumor growth. Together with its excellent safe profile, the proposed formulation suggests potential utility as a practical gene delivery system for treatment of intractable diseases.
27576084	0	9	Polymeric	T104,T122	C0032521
27576084	10	23	Nanostructure	T073	C1450053
27576084	38	64	Multifunctional Components	T077	C1705248
27576084	74	79	Tumor	T191	C0027651
27576084	82	99	Targeted Delivery	T063	C0920677
27576084	103	117	Antiangiogenic	T039	C3179230
27576084	118	122	Gene	T028	C0017337
27576084	127	139	Tumor Growth	T191	C0598934
27576084	140	151	Suppression	T080	C2700409
27576084	152	170	Nucleic acid-based	T114,T123	C0028606
27576084	171	178	therapy	T061	C0087111
27576084	196	221	revolutionary methodology	T078	C3266812
27576084	226	235	treatment	T169	C1522326
27576084	243	251	diseases	T047	C0012634
27576084	263	270	protein	T116,T123	C0033684
27576084	271	282	dysfunction	T077	C3887504
27576084	293	300	lack of	T080	C0332268
27576084	301	313	systemically	T169	C0205373
27576084	314	324	applicable	T080	C1706839
27576084	325	351	synthetic delivery systems	T063	C0920677
27576084	380	398	local applications	T046	C1393254
27576084	417	426	DNA-based	T114,T123	C0012854
27576084	427	434	therapy	T061	C0087111
27576084	454	474	poor bioavailability	T081	C0005508
27576084	482	506	systemic administrations	UnknownType	C0678812
27576084	547	555	multiple	T081	C0439064
27576084	556	582	chemistry-based strategies	T059	C3178923
27576084	592	603	manufacture	T057	C0870840
27576084	611	637	gene delivery formulations	T063	C0920677
27576084	648	656	improved	T033	C0184511
27576084	657	669	tolerability	T080	C4053931
27576084	673	676	DNA	T114,T123	C0012854
27576084	684	693	enzymatic	T044	C1511131
27576084	694	705	degradation	T044	C0314674
27576084	713	723	biological	T080	C0205460
27576084	724	730	milieu	T082	C0014406
27576084	735	754	prolonged retention	T043	C1753315
27576084	807	831	distinctive multilayered	T080	C0205556
27576084	832	842	functional	T169	C0205245
27576084	843	855	architecture	T082	C1254362
27576084	857	868	plasmid DNA	T114,T123	C0032136
27576084	870	874	pDNA	T114,T123	C0032136
27576084	880	907	electrostatically complexed	T067	C2348396
27576084	913	921	cationic	T104	C0007447
27576084	922	934	poly(lysine)	T116	C0032426
27576084	936	944	polyplex	T104,T122	C0032521
27576084	953	961	interior	T082	C0205102
27576084	962	966	pDNA	T114,T123	C0032136
27576084	967	976	reservoir	T082	C1254362
27576084	996	1008	cross-linked	T070	C0178576
27576084	1012	1017	redox	T044	C0030012
27576084	1020	1030	responsive	T169	C0205342
27576084	1031	1040	disulfide	T104	C0012771
27576084	1041	1054	cross-linking	T169	C0332220
27576084	1071	1081	occurrence	T079	C2745955
27576084	1085	1093	polyplex	T104,T122	C0032521
27576084	1094	1105	disassembly	T052	C1707798
27576084	1114	1131	exchange reaction	T044	C1148560
27576084	1141	1151	biological	T080	C0205460
27576084	1152	1170	charged components	T196	C0022023
27576084	1183	1187	pDNA	T114,T123	C0032136
27576084	1188	1197	reservoir	T082	C1254362
27576084	1227	1237	sequential	T080	C1705294
27576084	1238	1254	thermoresponsive	T169	C0205245
27576084	1255	1282	poly(N-isopropylacrylamide)	T109,T122	C0071490
27576084	1283	1291	palisade	T033	C1704513
27576084	1299	1319	intermediate barrier	T033	C1704513
27576084	1326	1339	biocompatible	T122	C0005479
27576084	1340	1351	hydrophilic	T080	C0475370
27576084	1352	1373	poly(ethylene glycol)	T109,T121,T122	C0032483
27576084	1375	1378	PEG	T109,T121,T122	C0032483
27576084	1380	1385	shell	T080	C1948022
27576084	1417	1430	accessibility	T080	C0814423
27576084	1438	1448	biological	T080	C0205460
27576084	1449	1456	species	T185	C1705920
27576084	1475	1483	nuclease	T116,T126	C0597094
27576084	1484	1495	degradation	T169	C0243125
27576084	1503	1507	pDNA	T114,T123	C0032136
27576084	1528	1542	investigations	T058	C0220825
27576084	1576	1586	strategies	T041	C0679199
27576084	1614	1619	blood	T031	C0005767
27576084	1620	1629	retention	T046	C0268000
27576084	1659	1665	method	T170	C0025663
27576084	1676	1683	therapy	T061	C0087111
27576084	1685	1720	ligand cyclic (Arg-Gly-Asp) peptide	T116	C1685100
27576084	1755	1758	PEG	T109,T121,T122	C0032483
27576084	1780	1785	tumor	T191	C0027651
27576084	1788	1796	targeted	T169	C1521840
27576084	1797	1805	delivery	T077	C1524066
27576084	1810	1825	gene expression	T045	C0017262
27576084	1840	1854	antiangiogenic	T039	C3179230
27576084	1855	1859	gene	T028	C0017337
27576084	1867	1875	targeted	T169	C1521840
27576084	1876	1887	tumor cells	T025	C0597032
27576084	1904	1912	exerting	T040	C0015264
27576084	1913	1929	antiangiogenesis	T039	C3179230
27576084	1937	1943	tumors	T191	C0027651
27576084	1948	1958	abrogation	T079	C2746065
27576084	1962	1974	tumor growth	T191	C0598934
27576084	2052	2061	potential	T080	C3245505
27576084	2085	2105	gene delivery system	T063	C0920677
27576084	2110	2119	treatment	T169	C1522326
27576084	2123	2134	intractable	T169	C0205269
27576084	2135	2143	diseases	T047	C0012634